By Mwenya Mofya
The Zambia Medicines Regulatory Authority-ZAMRA has directed Health Care Professionals to restrict the prescribing of Fluoroquinolone and Quinolene antibiotics for infections where the benefits outweigh the potential risks.
This follows the safety alerts issued by the United States Food and Drug Administration and the South African Health Product Regulatory Authority on the review of the disabling and potentially long-lasting side effects associated with the named antibiotics.
ZAMRA has recommended that health care professionals should not use the drug to treat patients who have previously had serious side effects from the antibiotics.
ZAMRA public relations officer Ludovic Mwape says the antibiotics should be used with caution especially for elderly patients with kidney problems or those who have had organ transplantation.